Abstract
Interferon-β1b treatment ¶in relapsing-remitting multiple ¶sclerosis can frequently induce ¶systemic side effects such as ¶flu-like symptoms with fever. In vitro stimulation of peripheral blood leukocytes with interferon-β1b before the beginning of therapy shows ¶that patients who develop fever generally have increased levels of interleukin-6.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 28 July 1999/Received in revised form: 26 October 1999/Accepted: 17 November 1999
Rights and permissions
About this article
Cite this article
Montalban, X., Durán, I., Río, J. et al. Can we predict flu-like symptoms in patients with multiple sclerosis treated with interferon-β?. J Neurol 247, 259–262 (2000). https://doi.org/10.1007/s004150050580
Issue Date:
DOI: https://doi.org/10.1007/s004150050580